In the Barretina Sarcoma dataset, NCAPD2 was overexpressed in Myxofibrosarcoma, Pleomorphic Liposarcoma, and Leiomyosarcoma with 2.627 (p = 4.43E-9), 2.118 (p = 1.21E-6) and 2.361 (p = 9.55E-8) fold changes. This evidence concerns the gene NCAPD2 and pleomorphic liposarcoma.